How to buy Tilray (TLRY) stock

Tilray, Inc is a drug manufacturers-specialty & generic business based in the US. Tilray shares (TLRY) are listed on the NASDAQ and all prices are listed in US Dollars. Tilray employs 1,200 staff and has a trailing 12-month revenue of around 0.00.

Tilray stock price (NASDAQ: TLRY)

Use our graph to track the performance of TLRY stocks over time.

Tilray shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$20.22
52-week range	$4.41 - $55.01
50-day moving average	$17.40
200-day moving average	$19.96
Wall St. target price	$18.82
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.23

Buy Tilray shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Tilray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Tilray, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tilray price performance over time

Historical closes compared with the close of $20.22 from 2021-06-08

1 week (2021-07-16)	N/A
1 month (2021-06-25)	11.10%
3 months (2021-04-27)	14.11%
6 months (2021-01-23)	N/A

1 year (2020-07-23)	N/A
2 years (2019-07-23)	N/A
3 years (2018-07-23)	N/A
5 years (2016-07-23)	N/A

Is Tilray under- or over-valued?

Valuing Tilray stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tilray's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Tilray's EBITDA

Tilray's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9 million.

The EBITDA is a measure of a Tilray's overall financial performance and is widely used to measure a its profitability.

Tilray financials

Revenue TTM	$611.1 million
Gross profit TTM	$191 million
Return on assets TTM	-1.31%
Return on equity TTM	-34.14%
Profit margin	-95.82%
Book value	$3.02
Market capitalisation	$6.5 billion

TTM: trailing 12 months

Shorting Tilray shares

There are currently 28.6 million Tilray shares held short by investors – that's known as Tilray's "short interest". This figure is 3.8% down from 29.7 million last month.

There are a few different ways that this level of interest in shorting Tilray shares can be evaluated.

Tilray's "short interest ratio" (SIR)

Tilray's "short interest ratio" (SIR) is the quantity of Tilray shares currently shorted divided by the average quantity of Tilray shares traded daily (recently around 30.4 million). Tilray's SIR currently stands at 0.94. In other words for every 100,000 Tilray shares traded daily on the market, roughly 940 shares are currently held short.

However Tilray's short interest can also be evaluated against the total number of Tilray shares, or, against the total number of tradable Tilray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tilray's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Tilray shares in existence, roughly 60 shares are currently held short) or 0.0668% of the tradable shares (for every 100,000 tradable Tilray shares, roughly 67 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Tilray.

Find out more about how you can short Tilray stock.

Tilray share dividends

We're not expecting Tilray to pay a dividend over the next 12 months.

Tilray share price volatility

Over the last 12 months, Tilray's shares have ranged in value from as little as $4.41 up to $55.01. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tilray's is 2.6198. This would suggest that Tilray's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Tilray overview

Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc.

Frequently asked questions

What percentage of Tilray is owned by insiders or institutions?
Currently 4.651% of Tilray shares are held by insiders and 8.589% by institutions. How many people work for Tilray?
Latest data suggests 1,200 work at Tilray. When does the fiscal year end for Tilray?
Tilray's fiscal year ends in December. Where is Tilray based?
Tilray's address is: 98 Talbot Street West, Leamington, ON, Canada, N8H 1M8 What is Tilray's ISIN number?
Tilray's international securities identification number is: US88688T1007 What is Tilray's CUSIP number?
Tilray's Committee on Uniform Securities Identification Procedures number is: 88688T100